Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Hold” by Brokerages

Health Catalyst, Inc. (NASDAQ:HCAT) has earned a consensus rating of “Hold” from the thirteen research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $2.7727.

Several brokerages recently commented on HCAT. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $1.00 price target (down from $5.00) on shares of Health Catalyst in a research note on Wednesday, March 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Health Catalyst in a research note on Friday, March 27th. Cantor Fitzgerald reissued a “neutral” rating on shares of Health Catalyst in a research note on Monday, May 11th. Stifel Nicolaus reduced their price objective on Health Catalyst from $3.75 to $2.00 and set a “hold” rating on the stock in a research note on Friday, March 13th. Finally, Citigroup reduced their price objective on Health Catalyst from $2.75 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, March 13th.

Health Catalyst Price Performance

Shares of HCAT stock opened at $1.40 on Friday. The stock’s fifty day simple moving average is $1.26 and its 200 day simple moving average is $1.89. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market cap of $103.45 million, a price-to-earnings ratio of -0.38 and a beta of 1.63. Health Catalyst has a one year low of $0.96 and a one year high of $4.29.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings results on Monday, May 11th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of $0.01 by $0.01. The business had revenue of $70.76 million for the quarter, compared to analyst estimates of $69.24 million. Health Catalyst had a negative return on equity of 3.52% and a negative net margin of 87.69%. On average, analysts expect that Health Catalyst will post -0.28 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Health Catalyst

A number of institutional investors and hedge funds have recently bought and sold shares of HCAT. AQR Capital Management LLC boosted its stake in Health Catalyst by 816.8% in the first quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock worth $763,000 after purchasing an additional 149,981 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Health Catalyst by 7.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock worth $163,000 after purchasing an additional 2,624 shares in the last quarter. Focus Partners Wealth acquired a new position in Health Catalyst in the first quarter worth $46,000. Geode Capital Management LLC boosted its stake in Health Catalyst by 11.4% in the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after purchasing an additional 169,580 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in Health Catalyst by 13.5% in the second quarter. Rhumbline Advisers now owns 101,986 shares of the company’s stock worth $384,000 after purchasing an additional 12,127 shares in the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.